MALDI Biotyper: Rapid Microbial & Proteomic Profiling
- Drug Discovery & Preclinical
- Monoclonal Antibodies
- Antibody-Drug Conjugates
- Vaccines (Prophylactic & Therapeutic)
- Cell & Gene Therapies (CGT)
- Allergy & Hypersensitivity
- Biomarker
- High-Dimensional Single-Cell Analysis by Flow Cytometry
- High-Throughput Cytokine & Chemokine Profiling by Multiplexing
- Biomarkers via Advanced IHC & Spatial Imaging
- Rare Cellular Functional Biomarkers by ELISPOT
- Real-Time Kinetic Biomarkers by IncuCyte S3
- Genomic Biomarker Analysis by qPCR & Droplet Digital PCR
- Seahorse XF: Immunometabolism & Bioenergetics
- MALDI Biotyper: Rapid Microbial & Proteomic Profiling
- Sapidyne KinExA
- Robust Protein Quantification by ELISA
- Advanced LNP Formulation & Screening – Unchained Labs Sunshine
- Translational & Clinical Research
- Immunogenicity Risk Assessment & Immunotoxicology
- Regulated Bioanalysis: PK, PD & Soluble Biomarkers
- Histopathology & Spatial Biology
- Advanced Flow Cytometry & Cellular Immunology
- Molecular Bioanalysis & Genomic Profiling
- Functional Potency & Ex Vivo Translational Models
- Central Laboratory & Clinical Trial Sample Management
- Dermo-Cosmetics & FMCG
- Nutraceuticals & Wellness
- Biorepository
MALDI Biotyper: Rapid Microbial & Proteomic Profiling
As therapeutic modalities scale and evolve, traditional, labor-intensive biochemical assays are no longer sufficient to maintain rigorous production timelines. We utilize the Bruker MALDI Biotyper®, an industry-leading system based on MALDI-TOF mass spectrometry to provide rapid, unbiased microbial identification down to the species level within minutes. By determining the unique proteomic fingerprint of unknown microorganisms and matching it against an extensive reference library, we ensure unparalleled precision and traceability for your most critical manufacturing processes.
Our advanced capabilities support the following critical applications:
Rapid Microbial Identification:
This approach replaces slow traditional assays with high-throughput molecular fingerprinting. It delivers accurate, in-house identification of demanding microorganisms, including anaerobic bacteria and fungi, in a fraction of the time.
Environmental Monitoring & Isolate Identification:
The system enables definitive surveillance of manufacturing facilities by providing rapid, unbiased identification of isolates down to the species level.
Contamination Source Identification:
Tracking facility contaminants relies on comparing unknown organisms to a ready-to-use reference library covering thousands of species. This rapid identification translates to high cost savings by preventing costly production line downtime and lost product shipments.
Sterility Testing Support:
The system provides a rapid, highly accurate solution for identifying microbial isolates. This speed accelerates actionable decision-making and root-cause analysis in time-critical scenarios.
Microbial Quality Control for Cell & Gene Therapy Manufacturing:
The platform supports complete workflow traceability and regulatory compliance. This rigorous compliance is crucial for managing the short shelf-life and unique safety requirements of live biotherapeutics, T-cell therapies, and non-viral gene delivery systems.